Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 19 and 64 years old
- People who have been diagnosed with type 2 diabetes and whose blood sugar control measure (called HbA1c) is between 5.7% and 9.0%
- People who are currently doing less than 150 minutes of moderate to vigorous physical activity per week
Who may not be able to join:
- People who have a long-term bone, muscle, or joint condition, or who have had a heart or blood vessel event (such as a heart attack or stroke) within the last 2 years, that would prevent them from exercising
- People whose type 2 diabetes medications have not been stable for the past 3 months
- People who have a condition that prevents the safe use of blood flow restriction, such as peripheral vascular disease (a condition affecting blood circulation in the limbs)
- People who have been told they have low iron levels or anaemia, or who are currently being treated for either of these
- People who have been diagnosed with a condition that affects red blood cells, such as sickle cell anaemia or poikilocytosis (confirm with trial site)
- People who are currently living with any heart or blood vessel disease that would make it unsafe for them to participate in exercise
- People who are currently taking a medication that would interfere with the ability of a heart rate monitor to accurately measure exercise intensity
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 250-807-9876
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in T-cell oxygen consumption rate (OCR) measured before and after the 6-week intervention
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.